These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7102506

  • 1. Influence of blood sampling site and technique on thromboxane concentrations in patients with ischemic heart disease.
    Hirsh PD, Firth BG, Campbell WB, Willerson JT, Hillis LD.
    Am Heart J; 1982 Aug; 104(2 Pt 1):234-7. PubMed ID: 7102506
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
    Mehta J, Mehta P, Feldman RL, Horalek C.
    Am Heart J; 1984 Feb; 107(2):286-92. PubMed ID: 6695662
    [Abstract] [Full Text] [Related]

  • 3. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina.
    Neri Serneri GG, Gensini GF, Abbate R, Prisco D, Rogasi PG, Laureano R, Casolo GC, Fantini F, Di Donato M, Dabizzi RP.
    Am Heart J; 1985 Apr; 109(4):732-8. PubMed ID: 3984828
    [Abstract] [Full Text] [Related]

  • 4. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M, Kuzuya T, Inoue M, Kodama K, Fukushima M, Abe H.
    Adv Myocardiol; 1980 Apr; 2():397-405. PubMed ID: 7423053
    [Abstract] [Full Text] [Related]

  • 5. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
    Hirsh PD, Firth BG, Campbell WB, Dehmer GJ, Willerson JT, Hillis LD.
    Am J Cardiol; 1983 Mar 01; 51(5):727-33. PubMed ID: 6829431
    [Abstract] [Full Text] [Related]

  • 6. Effect of atrial pacing on intracoronary thromboxane production in coronary artery disease.
    Martin JL, Wilson JR, Burch JW, Untereker WJ, Laskey W, Ferraro N, Hirshfeld JW.
    J Am Coll Cardiol; 1983 May 01; 1(5):1194-200. PubMed ID: 6833660
    [Abstract] [Full Text] [Related]

  • 7. [Myocardial ischemia during exertion. Correlations between blood levels of thromboxane B2 and changes in coronary flow and resistance].
    De Servi S, Vidale E, Mussini A, Cafiso A, Gavazzi A, Falcone C, Bramucci E, Angoli L, Ferrario M, Ghio S.
    G Ital Cardiol; 1985 Jan 01; 15(1):5-9. PubMed ID: 4007353
    [Abstract] [Full Text] [Related]

  • 8. Role of thromboxanes in vasotonic versus vaso-occlusive angina.
    Lewy RI.
    Arch Mal Coeur Vaiss; 1983 Feb 01; 76 Spec No():13-6. PubMed ID: 6407435
    [Abstract] [Full Text] [Related]

  • 9. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
    Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT.
    N Engl J Med; 1981 Mar 19; 304(12):685-91. PubMed ID: 6894016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations.
    Rehr RB, Jackson JA, Winniford MD, Campbell WB, Hillis LD.
    Am J Cardiol; 1984 Nov 01; 54(8):971-4. PubMed ID: 6437206
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion.
    Peterson MB, Huttemeier PC, Zapol WM, Martin EG, Watkins WD.
    Am J Physiol; 1982 Sep 01; 243(3):H471-9. PubMed ID: 7051860
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
    Tanabe M, Terashita Z, Nishikawa K, Hirata M.
    J Cardiovasc Pharmacol; 1984 Sep 01; 6(3):442-8. PubMed ID: 6202970
    [Abstract] [Full Text] [Related]

  • 14. Thromboxane A2 as an enhancing factor of coronary vasospasticity in variant angina.
    Ohmori M, Kuzuya T, Kodama K, Nanto S, Kamada T, Tada M.
    Jpn Circ J; 1987 May 01; 51(5):495-502. PubMed ID: 3626009
    [Abstract] [Full Text] [Related]

  • 15. Coronary spasm, prostaglandin and HLA factors.
    Numano F, Aizawa T, Nomura S, Yajima M, Fujii J.
    Jpn Circ J; 1985 Jan 01; 49(1):119-27. PubMed ID: 3855470
    [Abstract] [Full Text] [Related]

  • 16. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock.
    Sakanishi N, Tsunoda Y, Takekawa K, Ikezono E.
    Bull Tokyo Med Dent Univ; 1983 Jun 01; 30(2):37-46. PubMed ID: 6580966
    [Abstract] [Full Text] [Related]

  • 17. Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations.
    De Servi S, Ferrario M, Rondanelli R, Corsico G, Poma E, Ghio S, Mussini A, Angoli L, Bramucci E, Bré E.
    Am Heart J; 1987 Sep 01; 114(3):511-5. PubMed ID: 3630891
    [Abstract] [Full Text] [Related]

  • 18. [Protein binding of thromboxane--one of the sources of error in thromboxane determination].
    Wirthumer-Hoche C, Sinzinger H.
    Wien Klin Wochenschr; 1985 Mar 15; 97(6):282-5. PubMed ID: 3993037
    [Abstract] [Full Text] [Related]

  • 19. Thromboxane and prostacyclin changes during cardiopulmonary bypass with and without pulsatile flow.
    Watkins WD, Peterson MB, Kong DL, Kono K, Buckley MJ, Levine FH, Philbin DM.
    J Thorac Cardiovasc Surg; 1982 Aug 15; 84(2):250-6. PubMed ID: 6980332
    [Abstract] [Full Text] [Related]

  • 20. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
    Ylikorkala O, Puolakka J, Viinikka L.
    Am J Obstet Gynecol; 1982 Mar 01; 142(5):573-6. PubMed ID: 7036746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.